Drug intelligence / Profile preview

[68Ga]-DOTA-Z1085

Development stage
Preclinical
Lead developer
Vrije University Medical Center
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

[68Ga]-DOTA-Z1085 is a radiopharmaceutical PET imaging tracer designed to target the pro-inflammatory cytokine tumour necrosis factor (TNF). It consists of a small engineered affibody molecule, Z1085, which has high binding affinity for TNF, conjugated to the chelator DOTA and radiolabeled with Gallium-68. The tracer is being developed for the non-invasive assessment of TNF distribution and availability in patients with Rheumatoid Arthritis (RA), potentially allowing for patient stratification and treatment monitoring. Preclinical studies in rat models of arthritis have demonstrated its ability to accumulate in inflamed joints with a high signal-to-background ratio, correlating with synovial inflammation and macrophage infiltration.

Other names
68Ga-DOTA-Z1085TNF-specific affibody PET tracer
02

Targets

SSTR5 (Somatostatin receptor 5)SSTR2 (Somatostatin receptor type 2)

Beyond the preview

Go deeper on [68Ga]-DOTA-Z1085.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]-DOTA-Z1085.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call